Cerebrovascular compliance is not associated with acute mountain sickness following staged ascent to 4300 m

被引：0
|
作者：
Guerriere, Katelyn [1 ]
Beidleman, Beth [1 ]
Fulco, Charles [1 ]
Kenefick, Robert [1 ]
Staab, Janet [1 ]
Andrew, Sean [1 ]
Muza, Stephen [1 ]
机构：
[1] US Army Res Inst Environm Med, Natick, MA USA
来源：
FASEB JOURNAL | 2014年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
708.3
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Acute Mountain Sickness is Reduced Following 2 Days of Staging During Subsequent Ascent to 4300 m
    Beidleman, Beth A.
    Fulco, Charles S.
    Glickman, Ellen L.
    Cymerman, Allen
    Kenefick, Robert W.
    Cadarette, Bruce S.
    Andrew, Sean P.
    Staab, Janet E.
    Sils, Ingrid V.
    Muza, Stephen R.
    [J]. HIGH ALTITUDE MEDICINE & BIOLOGY, 2018, 19 (04) : 329 - 338
  • [2] Efficacy of Residence at Moderate Versus Low Altitude on Reducing Acute Mountain Sickness in Men Following Rapid Ascent to 4300 m
    Staab, Janet E.
    Beidleman, Beth A.
    Muza, Stephen R.
    Fulco, Charles S.
    Rock, Paul B.
    Cymerman, Allen
    [J]. HIGH ALTITUDE MEDICINE & BIOLOGY, 2013, 14 (01) : 13 - 18
  • [3] Elevated sympathoadrenal response following active ascent to 3,600m is not associated with acute mountain sickness
    Berkemeier, Quint
    Figueiredo, Peter
    Landspurg, Steven
    Staab, Janet
    Karl, James
    [J]. PHYSIOLOGY, 2024, 39
  • [4] Intermittent altitude exposures reduce acute mountain sickness at 4300 m
    Beidleman, BA
    Muza, SR
    Fulco, CS
    Cymerman, A
    Ditzler, D
    Stulz, D
    Staab, JE
    Skrinar, GS
    Lewis, SF
    Sawka, MN
    [J]. CLINICAL SCIENCE, 2004, 106 (03) : 321 - 328
  • [5] Two Days of Staging at Moderate Altitude Reduces Acute Mountain Sickness Upon Further Ascent to 4300 m in Unacclimatized Lowlanders
    Beidleman, Beth A.
    Fulco, Charles S.
    Kenefick, Robert W.
    Cymerman, Allen
    Staab, Janet E.
    Muza, Stephen R.
    [J]. FASEB JOURNAL, 2013, 27
  • [6] Heart rate variability changes at 2400 m altitude predicts acute mountain sickness on further ascent at 3000-4300 m altitudes
    Karinen, Heikki M.
    Uusitalo, Arja
    Vaha-Ypya, Henri
    Kahonen, Mika
    Peltonen, Juha E.
    Stein, Phyllis K.
    Viik, Jari
    Tikkanen, Heikki O.
    [J]. FRONTIERS IN PHYSIOLOGY, 2012, 3
  • [7] Effect of Six Days of Staging on Physiologic Adjustments and Acute Mountain Sickness during Ascent to 4300 Meters
    Beidleman, Beth A.
    Fulco, Charles S.
    Muza, Stephen R.
    Rock, Paul B.
    Staab, Janet E.
    Forte, Vincent A.
    Brothers, Michael D.
    Cymerman, Allen
    [J]. HIGH ALTITUDE MEDICINE & BIOLOGY, 2009, 10 (03) : 253 - 260
  • [8] Cerebral vasomotor reactivity and acute mountain sickness in volunteers at 4300M.
    Jansen, GF
    Krins, A
    Basnyat, B
    [J]. STROKE, 1996, 27 (04) : 798 - 798
  • [9] Altitude acclimatization and acute mountain sickness during a graded ascent to 5896 m
    Muza, Stephen Raymond
    Kenefick, Robert W.
    Andrew, Sean P.
    Beidleman, Beth A.
    Fulco, Charles S.
    Hamilton, Scott W.
    [J]. FASEB JOURNAL, 2013, 27
  • [10] Imparied insulin sensitivity in the early hours following either active or passive ascent to 3600m is associated with acute mountain sickness susceptibility
    Reitnauer, Kyle
    Beidleman, Beth
    Landspurg, Steven
    Buller, Mark
    Femling, Jon
    [J]. PHYSIOLOGY, 2024, 39
12345